Oncotarget

Vol 11, No 47

November 24, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 47 of Oncotarget features Figure 4, "Methylation sensitive restriction sites in target cDMRs," by Chapman, et al.

Table of Contents

Research Perspectives

The significance of ovarian fibrosis

The significance of ovarian fibrosis

https://doi.org/10.18632/oncotarget.27822

David A. Landry, Het T. Vaishnav,  and Barbara C. Vanderhyden
4366-4370
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Treatment of elderly patients with refractory/relapsed multiple myeloma: oral drugs adherence and the COVID-19 outbreak

Treatment of elderly patients with refractory/relapsed multiple myeloma: oral drugs adherence and the COVID-19 outbreak

https://doi.org/10.18632/oncotarget.27819

Flávia Dias Xavier, Fernando Sergio Blumm Ferreira,  and Rodrigo Martins Abreu
4371-4386
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Research Papers

Selective amplification of hypermethylated DNA from diverse tumor types via MSRE-PCR

Selective amplification of hypermethylated DNA from diverse tumor types via MSRE-PCR

https://doi.org/10.18632/oncotarget.27825

Karen B. Chapman,  and Brandon W. Higgs
4387-4400
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Predictors of immunotherapy benefit in Merkel cell carcinoma

Predictors of immunotherapy benefit in Merkel cell carcinoma

https://doi.org/10.18632/oncotarget.27823

Alec J. Kacew, Harita Dharaneeswaran, Gabriel J. Starrett, Manisha Thakuria, Nicole R. LeBoeuf, Ann W. Silk, James A. DeCaprio,  and Glenn J. Hanna
4401-4410
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico

Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico

https://doi.org/10.18632/oncotarget.27824

Zeju Jiang, Xinlai Sun, Zhao Wu, Albert Alhatem, Ruifang Zheng, Dongfang Liu, Yaqun Wang, Dibyendu Kumar, Changqing Xia, Bei You, He Wang, Chen Liu,  and Jie-Gen Jiang
4411-4420
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Ibuprofen disrupts a WNK1/GSK3β/SRPK1 protein complex required for expression of tumor-related splicing variant RAC1B in colorectal cells

Ibuprofen disrupts a WNK1/GSK3β/SRPK1 protein complex required for expression of tumor-related splicing variant RAC1B in colorectal cells

https://doi.org/10.18632/oncotarget.27816

Vânia Gonçalves, Andreia F.A. Henriques, Paulo Matos,  and Peter Jordan
4421-4437
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Effect of liver fibrosis on survival in patients with intrahepatic cholangiocarcinoma: a SEER population-based study

Effect of liver fibrosis on survival in patients with intrahepatic cholangiocarcinoma: a SEER population-based study

https://doi.org/10.18632/oncotarget.27820

Nimrod Adatto Levy, Guy Kern, Daniel Shepshelovich, Oren Shibolet, Rami Hershkoviz,  and Ofer Isakov
4438-4447
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Reduced CpG island methylation of the TBC1D8 gene may predict risk for osteoporosis in Chinese postmenopausal women

Reduced CpG island methylation of the TBC1D8 gene may predict risk for osteoporosis in Chinese postmenopausal women

https://doi.org/10.18632/oncotarget.24065

Qian-Qian Ma, Lv Lin, Qi Yao, Jun Yang, Yan Hu,  and Jing-Bo Yu
4448-4456
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Case Reports

A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial

A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial

https://doi.org/10.18632/oncotarget.27807

Guillermo de Velasco, Lucia Carril-Ajuria, Felix Guerrero-Ramos, Teresa Alonso-Gordoa, Juan F. Rodríguez-Moreno, Alberto Carretero, Maricruz Martin-Soberon, Federico de la Rosa-Kehrmann,  and Daniel Castellano
4457-4462
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC